Trenton, N.J. • Pharmaceutical industry heavyweights are teaming up to address a challenge that’s long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.
Ten top U.S. and European drugmakers have started a nonprofit organization, called TransCelerate BioPharma, to collaborate on the problem.
 |
Join the Discussion |
 |
Post a Comment |
Research productivity across the industry has been declining, with thousands of potential drugs failing for every one approved, but testing costs keep rising.
The new group will develop strategies to make it easier and quicker to set up and run clinical tests of experimental drugs.
Initial participants include Pfizer, Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, Abbott, GlaxoSmithKline, AstraZeneca, Sanofi, Boehringer Ingelheim and Genentech.
The group’s CEO, Garry Neil, says he expects to have initial results next summer.
-
Set your limits and then live accordingly
Published May 23, 2013 01:01:03AM -
SLCC has top veterans center for Utah student veterans
Published May 23, 2013 01:01:03AM -
West Jordan Council votes intent to expand mayor’s job
Published May 22, 2013 10:35:03PM -
Cross-dressing male robs Sandy bank
Published May 22, 2013 10:35:03PM
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
